Quince Therapeutics earnings were -$56.8M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest QNCX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$12.5M, up 126.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, QNCX reported annual earnings of -$56.8M, with 81.1% growth. The next QNCX earnings date is May 12, 2025.
Quince Therapeutics Earnings Reports & History FAQ
What were Quince Therapeutics's earnings last quarter?
On QNCX's earnings call on Invalid Date, Quince Therapeutics (NASDAQ: QNCX) reported Q4 2024 earnings per share (EPS) of -$0.28, up 33.33% year over year. Total QNCX earnings for the quarter were -$12.46 million. In the same quarter last year, Quince Therapeutics's earnings per share (EPS) was -$0.21.
The next QNCX earnings call is Invalid Date. Add QNCX to your watchlist to be reminded of Quince Therapeutics's next earnings date.
What was QNCX's earnings growth in the past year?
As of Quince Therapeutics's earnings date in Invalid Date, Quince Therapeutics's earnings has grown year over year. QNCX earnings in the past year totalled -$56.83 million.
Is Quince Therapeutics profitable or losing money?
As of the last Quince Therapeutics earnings report, Quince Therapeutics is currently losing money. Quince Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$56.83 million, a 81.07% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.